Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Alpha1-blockers effectively improve urinary symptoms in BPH, with alfuzosin and tamsulosin having fewer side effects.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Cedrol may help treat inflammatory bowel disease by improving gut health and function.

Some people have a genetic variation that makes them less effective at breaking down drugs.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Activated protein C helps protect mice from radiation damage.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Circ 0020938 slows down hair growth in cashmere goats.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Finasteride lowers cholesterol but doesn't reduce heart-related events.

Lack of Crif1 in hair follicle stem cells slows down hair growth in mice.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Ferulic acid may help control menstrual cycle-related epilepsy by affecting female hormones.

Neurosteroids help reduce seizures, but their withdrawal increases seizure activity.